NSC |
Compound |
Enrichment |
Correlation |
NSC 726195 |
2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one |
0.0145418727063286 |
0.39516291 |
NSC 732568 |
6,8-Dibromo-2-phenyl-3-[5?-amino6?(2??,3??-dichlorophenyl)1, 2,4-triazin-3-yl]quinazolin-4(3H)-one (SPC-IIIBr) |
0.0145418727063286 |
0.35763038 |
NSC 626876 |
2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride |
0.0149636429145596 |
0.34437756 |
NSC 671883 |
Null |
0.0149636429145596 |
0.44305612 |
NSC 683905 |
Null |
0.0166986251090031 |
0.17097722 |
NSC 698254 |
5'-Formyl-2,5-bis(2'-selenyl)-N-methylpyrrol |
0.0166986251090031 |
-0.0077315541 |
NSC 107124 |
Camptothecin Derivative |
0.0186186224062458 |
0.15524543 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0186186224062458 |
0.48002141 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0186186224062458 |
0.20030482 |
NSC 129518 |
Cyclopyrethrosin |
0.0186186224062458 |
0.13306347 |